DNA/GPS
About DNA/GPS
DNAGPS is located in Tampa, United States. A genomic-based platform for diagnosing systemic diseases is developed by the company. Retinal imaging and genetic mapping are integrated to enable healthcare providers to monitor and screen patients remotely from home. Conditions such as heart disease, Alzheimers, dementia, and Parkinsons are targeted for early detection. The founder is identified as Larry Perich, with operations centered in the healthcare and genomics sector.
- Headquarter Tampa, United States
- Founders Larry Perich
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
RetinalGeniX
(Jul 06, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of DNA/GPS
Detailed funding history for DNAGPS
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in DNA/GPS
DNA/GPS has secured backing from 1 investor. Prominent investors backing the company include RetinalGeniX.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical devices for diabetic retinopathy diagnosis are manufactured.
|
Locked | Locked | Locked |
Investor details for DNAGPS
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DNA/GPS
Investment portfolio details for DNAGPS
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DNAGPS
Detailed financials for DNAGPS
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dna/Gps Comparisons
Peer comparison for DNAGPS
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DNA/GPS
Detailed competitors of DNAGPS
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dna/Gps
Complete news archive for DNAGPS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DNA/GPS
DNA/GPS is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.
DNAGPS is located in Tampa, United States. A genomic-based platform for diagnosing systemic diseases is developed by the company. Retinal imaging and genetic mapping are integrated to enable healthcare providers to monitor and screen patients remotely from home. Conditions such as heart disease, Alzheimers, dementia, and Parkinsons are targeted for early detection. The founder is identified as Larry Perich, with operations centered in the healthcare and genomics sector.
DNA/GPS has 1 investor. Key investors include RetinalGeniX.